Stocks-AYTU-Aytu BioScience Inc

AYTU Aytu BioScience Inc

2.10 -0.20 (-8.70%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Invest

FINANCIAL SUMMARY

For the quarter ended 31/12/2022, Aytu BioScience Inc's revenues decreased by 4.98% and amounted to 26.28M. Net income decreased by 132.32% to -6.69M. Net assets decreased by 15.01% to 45.82M and EPS decreased from -0.06 to -43.04.
AYTU's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
55.45%
Net Profit Margin
-180.21%
Operating Margin
-23.12%
Return On Investment
-132.34%